Search results
OTC Solution for Erectile Dysfunction?
Medscape· 6 days agoTopical gel helped more than half of men achieve erection within 10 minutes, according to a new study.
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoUtilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies...
Earnings call: Cipher Pharmaceuticals reports strong Q1 with revenue up 20% By Investing.com
Investing.com· 1 day agoCipher Pharmaceuticals (OTC:CPHRF) Inc. (TSX:CPH) has released its Q1 2024 financial results,...
Marinus Verwijs Sells 1,981 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stock
ETF DAILY NEWS· 6 days agoAerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Marinus Verwijs sold 1,981 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold ...
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 5 days agoVTRS expects to complete the divestiture of its API business in India and OTC business by the end of...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days ago(NASDAQ: GDRX), Autodesk, Inc. (NASDAQ: ADSK), Global Cord Blood Corporation (OTC: CORBF), and Lincoln National Corporation (NYSE: LNC). Stockholders have until the deadlines ...
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zacks via Yahoo Finance· 5 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Earnings call: Trulieve reports increased revenue and improved margins By Investing.com
Investing.com· 2 days agoTrulieve Cannabis (OTC:TCNNF) Corporation (CSE: TRUL), a leading cannabis company, has reported a...
...Connecticut Marijuana Cultivation Facility, Expands Partnership With Michigan's C3 Industries -...
Benzinga· 3 days agoCannabis REIT NewLake Capital Partners, Inc. NLCP announced on Wednesday that it is acquiring a...
Teva stock gains on trial win, Q1 beat (NYSE:TEVA)
Seeking Alpha· 3 days agoTeva Pharmaceutical (TEVA) stock posts record gains due to better-than-expected Q1 revenue and positive Phase 3 trial results for its schizophrenia drug....